Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aphria

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Tilray Brands

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast Transcript)

The U.S.-listed shares of Canopy Growth Corp. edged up 0.5% in premarket trading Thursday, after the Canada-based cannabis company announced an agreement on a $750 million senior secured term loan with funds advised by King Street Capital Management L.P. The term loan, which matures on March 18, 2026, has a coupon of LIBOR plus 8.5% and has no amortization payments.

Canopy Growth agrees on $750 term loan with King Street

Provides further balance sheet flexibility for growth investments in our core markets   SMITHS FALLS, ON, March 18, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "Canopy" or the "Company") (TSX: WEED) (NASDAQ: CGC) is pleased to announce that it has entered into a credit agreement (the "Credit Agreement")  with Funds advised by King Street Capital Management, L.P. ("King Street").

Canopy Growth Announces US$750 Million Term Loan Financing

GrowGeneration Corp

Silver Spike Acquisition Corp

As cannabis becomes legal in Mexico and around the globe, the U.S. will be pressured to act. And the companies at the epicenter of this Marijuana Boom are the best weed stocks to buy.

The 3 Best Pot Stocks to Buy for Global Legalization

Aurora Cannabis

HEXO Corp

OrganiGram Holdings Inc.

It's about what's happening in a potentially powerful marijuana state.

Why These Top Marijuana Stocks Got Slammed Today

Cronos Group

Cannabis stocks moved higher on Monday after Governor Andrew Cuomo said New York is "very close" on legalizing the drug for recreational use. Shares of Tilray and Aphria traded up as much as 14% and 12%, respectively, while marijuana ETFs like the ETFMG Alternative Harvest and AdvisorShares Pure Cannabis ETFs were up as much as 4%.

Cannabis stocks surge after Governor Andrew Cuomo says New York is 'very close' on legalization

New York could be very close to legalizing recreational marijuana.

Why Canopy Growth, Hexo, Tilray, and Other Pot Stocks Soared Today

Two new cannabis markets could be on the way.

Why Canopy Growth Stock Jumped Today

Canopy Growth Corporation (CGC) Management Presents at BofA Securities Virtual Consumer & Retail Technology Conference (Transcript)

Mexico is getting closer to legalizing marijuana and the news has shares of several weed stocks heading higher on Thursday. The post Weed Stocks: ACB, CGC, TLRY, GRWG, APHA, CRON Light Up on Mexico Marijuana Legalization News appeared first on InvestorPlace.

Weed Stocks: ACB, CGC, TLRY, GRWG, APHA, CRON Light Up on Mexico Marijuana Legalization News

Stocks of the Canadian pot growers are reversing a recent downtrend today.

Why Canopy Growth, Organigram Holdings, and HEXO Shares Jumped Tuesday

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast)

The company announced the launch of a new product for the U.S. market.

Why Investors Shouldn't Get Too Excited About Canopy Growth's Latest Move

After being pumped up by Reddit traders in January, Canopy fell back to earth in February, despite solid earnings.

Why Canopy Growth Fell 18.1% in February

Cannabis growers and distributors dropped for a second straight week, falling with the broader market and on increased concerns about partisan sniping.

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

SNDL Inc.

Pot stocks like CGC, TLRY, APHA and SNDL stock are down today as investors shift risk preferences and eye inflation rates. The post CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

CGC stock continues to underperform its U.S. peers of late as concerns about how the company will expand in the U.S. over the long term. The post Why Canopy Growth Is Down 45% From Its Peak appeared first on InvestorPlace.

Why Canopy Growth Is Down 45% From Its Peak

GW Pharmaceuticals

Innovative Industrial Properties

Jazz Pharmaceuticals

Global X Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line. The post Don't Miss These 2 Ways To Play The Hot Marijuana Stocks Industry appeared first on Investor's Business Daily.

Don't Miss These 2 Ways To Play The Hot Marijuana Stocks Industry

CGC stock looks stands out among the crowd. The post Here's What Makes Canopy Growth Stock a Solid, Long-Term Cannabis Play appeared first on InvestorPlace.

Here's What Makes Canopy Growth Stock a Solid, Long-Term Cannabis Play

Marijuana stocks have been up and down for several years and still seek firm footing. Right now, these seven aren't worth your money.

7 Marijuana Stocks That Look Way Too Expensive Here

Why Marijuana Stocks Like Canopy Growth and Aphria Got Trashed on Thursday

SMITHS FALLS, ON, March 4, 2021 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) ("Canopy Growth" or "the Corporation") announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference...

Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021

Marijuana will provide the basis for many of tomorrow's blockbuster drugs. David Borun shows you how to invest in this burgeoning industry.

Investors: The Marijuana Boom Is Now

Off and on the price chart conditions are quickly shaping up for CGC stock investors to pull the trigger on a well-timed and secure purchase The post When and How to Buy Canopy Growth Stock With Street Cred appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn't matter if you have $500 in savings or $5 million.

When and How to Buy Canopy Growth Stock With Street Cred

Constellation Brands

It's cheap, profitable, growing, and has a bright future -- what more could you want from a pot stock?

News for Canopy Growth Stock (CGC)